JPRN-UMIN000041803招募中未知
Clinical significance of peripheral blood CD4+ T cell subpopulations for immune checkpoint inhibitor treatment - peripheral blood CD4+ T cell subpopulations for immune checkpoint inhibitor treatment
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with past history of an immune checkpoint inhibitor
研究者
相似试验
尚未招募
不适用
Role of CD4 cell counts in predicting disease outcome in covid positive patientsCTRI/2021/02/031096Government Medical College
已完成
1 期
Measurement of serum soluble CD4 levels in patients with external anogenital warts before and after intralesional injection of tuberculin purified protein derivativeUrological and Genital DiseasesPACTR202006534973105Mohamed Azab49
已完成
不适用
Evaluation of the benefit and the safety of a CD4-guided Highly Active Anti-Retroviral Therapy (HAART) interruption strategy in stable adult Human Immunodeficiency Virus (HIV)-infected patientsISRCTN75856952Spanish AIDS Research Network (Red de Investigacion en SIDA [RIS]) (Spain)170
招募中
不适用
Circulating CD4posCD28neg T cells in patients with chronic kidney disease;the relation with CMV latency and atherosclerotic disease.100022521002914910003216atherosclerosisNL-OMON31067Academisch Medisch Centrum280
已完成
不适用
Characterization of Circulating CD4+CD8+Double Positive and CD4-CD8- Double Negative T-Lymphocyte in children with beta-Thalassemia majorJPRN-UMIN000018950Faculty of medicine, University of Assiut, Assiut 71516, Egypt.80